3. Innate Pharma's senior management team will attend the Goldman Sachs 44th Annual Global Healthcare Conference, held from June 12-15 in Dana Point (USA).
7. Innate Pharma's portfolio includes lead programs such as lacutamab for advanced cutaneous T cell lymphomas and peripheral T cell lymphomas, and monalizumab developed in collaboration with AstraZeneca for non-small cell lung cancer.
9. Innate Pharma collaborates with biopharmaceutical companies like Sanofi and AstraZeneca, as well as leading research institutions, to advance innovation and research for the benefit of patients.